Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.91 and traded as low as $0.74. Pharma-Bio Serv shares last traded at $0.75, with a volume of 4,001 shares trading hands.
Pharma-Bio Serv Trading Up 2.0 %
The stock has a fifty day simple moving average of $0.83 and a 200-day simple moving average of $0.91. The company has a market capitalization of $17.22 million, a PE ratio of 25.01 and a beta of 0.55.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last issued its earnings results on Monday, March 18th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.03). The business had revenue of $2.38 million for the quarter, compared to analyst estimates of $5.00 million. Pharma-Bio Serv had a return on equity of 3.95% and a net margin of 4.05%. As a group, equities research analysts predict that Pharma-Bio Serv, Inc. will post 0.08 EPS for the current year.
Pharma-Bio Serv Company Profile
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Featured Articles
- Five stocks we like better than Pharma-Bio Serv
- 5 Top Rated Dividend Stocks to Consider
- Appleās Earnings Show Investors Its Strength and Its Weakness
- What is a Special Dividend?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Most Volatile Stocks, What Investors Need to Know
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.